Dr. Buell said the ARDS trial is designed for rapid, clinically oriented readouts: "we think we will have early readouts quite quickly, and we're setting up already to be publicly presenting these ...

The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...

Your AI isn't just learning from your data; it’s making dozens of untracked copies of it, leaving sensitive customer info ...

Process industries say it's quality data, not randomly gathered data mountains, that matter in the age of industrial AI. Its ...

Phison Electronics (8299TT), a global leader in NAND flash controllers and storage solutions, today announced that its Pascari D206V PCIe Gen5 data center SSD has received the prestigious COMPUTEX ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will be ...

A new study proves structured coaching and lifestyle intervention radically lower biological frailty and slow aging.

AI-driven data centers and crypto mining could send household electricity bills soaring by more than 50% in some states by ...

A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the ...

What if the next decisive intelligence advantage isn’t a recruited insider but a nation’s ability to model entire societies ...